文献速递母胎医学

孕中期发现的胎儿巨膀胱中ACTG2内脏肌病的产前诊断

Prenatal Diagnosis of ACTG2 Visceral Myopathy Presented With Fetal Megacystis Identified in the Second Trimester.
PubMed 文献 · Prenat Diagn · 2024-12-09

本文报告4例产前ACTG2内脏肌病病例,均在孕中期超声发现胎儿巨膀胱,经侵入性遗传学检查及三人组外显子测序检出可能致病或致病的ACTG2变异,其中3例为新发变异,1例遗传自儿童期即有平滑肌功能障碍症状的母亲。作者认为对孕中期孤立性巨膀胱胎儿应高度关注ACTG2内脏肌病,单基因病遗传学诊断有助于父母咨询、妊娠管理和再发风险评估。

要点

  • 孕中期超声发现胎儿巨膀胱时,应关注ACTG2内脏肌病。
  • 4例均经三人组外显子测序检出可能致病或致病的ACTG2变异。
  • 3例变异为新发,1例遗传自儿童期有平滑肌功能障碍症状的母亲。

核心结论

  • 对孕中期孤立性巨膀胱胎儿应高度关注ACTG2内脏肌病。
  • 与胎儿巨膀胱相关的单基因病遗传学诊断有助于父母咨询、妊娠管理和未来妊娠再发风险评估。

研究设计与样本

  • 本文报告4例产前ACTG2内脏肌病病例。
  • 4例均在孕中期经超声发现胎儿巨膀胱,均于孕期接受侵入性遗传学检查,三人组外显子测序检出胎儿可能致病或致病的ACTG2变异。

主要发现

  • 4例胎儿均表现为孕中期超声发现的胎儿巨膀胱。
  • 4例胎儿均检出可能致病或致病的ACTG2变异。
  • 4例变异中3例为新发,1例遗传自儿童期即有平滑肌功能障碍症状的母亲。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Variants of the ACTG2 gene cause autosomal dominant ACTG2 visceral myopathy, a disorder of smooth muscle dysfunction of the bladder and gastrointestinal system. Bladder involvement can behave as fetal megacystis (FM). We report four prenatal cases of ACTG2 visceral myopathy. All four cases presented with FM identified by ultrasound in the second trimester. All had invasive genetic investigations during pregnancy, and trio exome sequencing revealed likely pathogenic or pathogenic ACTG2 variants in the fetuses. Three of the four variants were de novo, and one was inherited form mother who had symptoms of smooth muscle dysfunction since childhood. ACTG2 visceral myopathy is the most concern in fetuses with isolated second-trimester megacystis. Genetic diagnosis of single gene disorders associated with FM is useful in parental counseling, pregnancy management and risk assessment of recurrence in future pregnancy.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Yu QX, Liu N, Zhen L, et al. Prenatal Diagnosis of ACTG2 Visceral Myopathy Presented With Fetal Megacystis Identified in the Second Trimester. Prenat Diagn. 2024. PMID: 39653395. doi:10.1002/pd.6726

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。